Recombinant RSV (Palivizumab Biosimilar) 抗体
This anti-RSV (Palivizumab Biosimilar) antibody is a Humanized Chimeric antibody detecting RSV (Palivizumab Biosimilar) in . Suitable for Human respiratory syncytial virus A.
Quick Overview for Recombinant RSV (Palivizumab Biosimilar) 抗体 (ABIN7597894)
抗原
RSV (Palivizumab Biosimilar)
抗体类型
Recombinant Antibody
适用
Human respiratory syncytial virus A
宿主
Humanized
克隆类型
Chimeric
标记
This RSV (Palivizumab Biosimilar) antibody is un-conjugated
应用范围
请咨询
质量等级
Research Grade
-
-
Expression System
- Mammalian cells
-
原理
- Research Grade Palivizumab Biosimilar Antibody
-
特异性
- F, Fusion glycoprotein F0, Fusion glycoprotein F2, p27, Intervening segment, Pep27, Peptide 27, Fusion glycoprotein F1
-
纯化方法
- Protein A or G purified from cell culture supernatant.
-
纯度
- >95 % by SDS-PAGE.
-
亚型
- IgG1, kappa
-
-
-
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 2.47 mg/mL
-
缓冲液
- 0.01M PBS, pH 7.4.
-
储存条件
- 4 °C,-20 °C,-80 °C
-
储存方法
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
-
有效期
- 12 months
-
-
- RSV (Palivizumab Biosimilar)
-
别名
- Palivizumab Biosimilar
-
物质类
- Biosimilar
-
背景
- F, Fusion glycoprotein F0, Fusion glycoprotein F2, p27, Intervening segment, Pep27, Peptide 27, Fusion glycoprotein F1
-
UniProt
- P03420
-
CAS-编号
- 188039-54-5
抗原
-
You are here:
